Our finding that AR deletion results in failure of tumor formation following Pten inactivation could be due to differences between CARNs and bulk luminal cells and/or to differences due to Pten loss in the regressed versus hormonally intact prostate epithelium. The gene discussed is AR; the disease is neoplasm.